Profit Or Loss [Abstract]

ABIONYX Pharma - Filing #879713

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
675,000 EUR
Cost of sales
416,000 EUR
Other gains (losses)
37,000 EUR
Profit (loss) from operating activities
5 952 EUR
2 968 EUR
Finance income
307,000 EUR
1 195 EUR
Finance costs
177,000 EUR
113,000 EUR
Profit (loss)
5 822 EUR
5 822 EUR
1 886 EUR
1 886 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
23.00
8.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
22.00
8.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.